Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol

被引:7
|
作者
Jerene, Degu [1 ]
Levy, Jens [1 ]
van Kalmthout, Kristian [1 ]
Rest, Job van [1 ]
McQuaid, Christopher Finn [2 ]
Quaife, Matthew [2 ]
Charalambous, Salome [3 ]
Gamazina, Katya [4 ]
Garfin, A. M. Celina [5 ]
Mleoh, Liberate [6 ]
Terleieva, Yana [7 ]
Bogdanov, Alexsey [4 ]
Maraba, Noriah [3 ]
Fielding, Katherine [2 ]
机构
[1] KNCV TB Fdn, Div TB Eliminat & Hlth Syst Strengthening, The Hague, Netherlands
[2] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, TB Ctr, Dept Infect Dis Epidemiol, London, England
[3] Aurum Inst, Johannesburg, South Africa
[4] Program Appropriate Technol Hlth, Kiev, Ukraine
[5] Dis Prevent & Control Bur, Dept Hlth, Infect Dis Prevent & Control Div, Manila, Philippines
[6] Dept Prevent Serv, Natl TB & Leprosy Programme, Dodoma, Tanzania
[7] Dept Coordinat TB Treatment Programs, Kiev, Ukraine
来源
BMJ OPEN | 2023年 / 13卷 / 03期
关键词
Tuberculosis; Public health; Tropical medicine; Epidemiology;
D O I
10.1136/bmjopen-2022-068685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Successful treatment of tuberculosis depends to a large extent on good adherence to treatment regimens, which relies on directly observed treatment (DOT). This in turn requires frequent visits to health facilities. High costs to patients, stigma and burden to the health system challenged the DOT approach. Digital adherence technologies (DATs) have emerged as possibly more feasible alternatives to DOT but there is conflicting evidence on their effectiveness and feasibility. Our primary objective is to evaluate whether the implementation of DATs with daily monitoring and a differentiated response to patient adherence would reduce poor treatment outcomes compared with the standard of care (SOC). Our secondary objectives include: to evaluate the proportion of patients lost to follow-up; to compare effectiveness by DAT type; to evaluate the feasibility and acceptability of DATs; to describe factors affecting the longitudinal engagement of patients with the intervention and to use a simple model to estimate the epidemiological impact and cost-effectiveness of the intervention from a health system perspective.Methods and analysis This is a pragmatic two-arm cluster-randomised trial in the Philippines, South Africa, Tanzania and Ukraine, with health facilities as the unit of randomisation. Facilities will first be randomised to either the DAT or SOC arm, and then the DAT arm will be further randomised into medication sleeve/labels or smart pill box in a 1:1:2 ratio for the smart pill box, medication sleeve/label or the SOC respectively. We will use data from the digital adherence platform and routine health facility records for analysis. In the main analysis, we will employ an intention-to-treat approach to evaluate treatment outcomes.Ethics and dissemination The study has been approved by the WHO Research Ethics Review Committee (0003296), and by country-specific committees. The results will be shared at national and international meetings and will be published in peer-reviewed journals.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Evaluating the effectiveness of the Play Active policy intervention and implementation support in early childhood education and care: a pragmatic cluster randomised trial protocol
    Andrea Nathan
    Emma Adams
    Stewart Trost
    Donna Cross
    Jasper Schipperijn
    Matthew McLaughlin
    Ashleigh Thornton
    Georgina Trapp
    Leanne Lester
    Phoebe George
    Elizabeth Wenden
    Hayley Christian
    BMC Public Health, 22
  • [42] Effectiveness and implementation success of a co-produced physical activity referral scheme in Germany: study protocol of a pragmatic cluster randomised trial
    Anja Weissenfels
    Sarah Klamroth
    Johannes Carl
    Inga Naber
    Eriselda Mino
    Wolfgang Geidl
    Peter Gelius
    Karim Abu-Omar
    Klaus Pfeifer
    BMC Public Health, 22
  • [43] Effectiveness and implementation success of a co-produced physical activity referral scheme in Germany: study protocol of a pragmatic cluster randomised trial
    Weissenfels, Anja
    Klamroth, Sarah
    Carl, Johannes
    Naber, Inga
    Mino, Eriselda
    Geidl, Wolfgang
    Gelius, Peter
    Abu-Omar, Karim
    Pfeifer, Klaus
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [44] Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting - A cluster randomized controlled trial
    Thiam, Sylla
    LeFevre, Andrea M.
    Hane, Fatoumata
    Ndiaye, Alimatou
    Ba, Fatoumata
    Fielding, Katherine L.
    Ndir, Moustapha
    Lienhardt, Christian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (04): : 380 - 386
  • [45] Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial
    Wei, Xiaolin
    Hicks, Joseph Paul
    Zhang, Zhitong
    Haldane, Victoria
    Pasang, Pande
    Li, Linhua
    Yin, Tingting
    Zhang, Bei
    Li, Yinlong
    Pan, Qiuyu
    Liu, Xiaoqiu
    Walley, John
    Hu, Jun
    LANCET, 2024, 403 (10430): : 913 - 923
  • [46] Evaluating the effectiveness and cost-effectiveness of the Smoking Treatment Optimisation in Pharmacies (STOP) intervention: protocol for a cluster randomised controlled trial
    Sohanpal, Ratna
    Jumbe, Sandra
    James, Wai-Yee
    Steed, Liz
    Yau, Tammy
    Rivas, Carol
    Madurasinghe, Vichithranie
    Houlihan, Colin
    Berdunisov, Vlad
    Taylor, Matthew
    Taylor, Stephanie J. C.
    Griffiths, Chris
    Eldridge, Sandra
    Walton, Robert
    TRIALS, 2019, 20 (1)
  • [47] Evaluating the effectiveness and cost-effectiveness of the Smoking Treatment Optimisation in Pharmacies (STOP) intervention: protocol for a cluster randomised controlled trial
    Ratna Sohanpal
    Sandra Jumbe
    Wai-Yee James
    Liz Steed
    Tammy Yau
    Carol Rivas
    Vichithranie Madurasinghe
    Colin Houlihan
    Vlad Berdunisov
    Matthew Taylor
    Stephanie J. C. Taylor
    Chris Griffiths
    Sandra Eldridge
    Robert Walton
    Trials, 20
  • [48] Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda
    Cattamanchi, Adithya
    Crowder, Rebecca
    Kityamuwesi, Alex
    Kiwanuka, Noah
    Lamunu, Maureen
    Namale, Catherine
    Tinka, Lynn Kunihira
    Nakate, Agnes Sanyu
    Ggita, Joseph
    Turimumahoro, Patricia
    Babirye, Diana
    Oyuku, Denis
    Berger, Christopher
    Tucker, Austin
    Patel, Devika
    Sammann, Amanda
    Stavia, Turyahabwe
    Dowdy, David
    Katamba, Achilles
    PLOS MEDICINE, 2021, 18 (05)
  • [49] Effectiveness of routine measurement of health-related quality of life in improving the outcomes of patients with musculoskeletal problems-a cluster randomised controlled trial: protocol paper
    Lam, Cindy
    Chin, Weng Yee
    Wong, Carlos King Ho
    Or, Kalun
    Fong, Daniel Yee Tak
    Cheung, Jason Pui Yin
    Chao, David Vai Kiong
    Wong, Eliza L. Y.
    Kind, Paul
    BMJ OPEN, 2020, 10 (12):
  • [50] The effect of a customised digital adherence tool on HIV treatment outcomes in young people living with HIV (YPLHIV) in Blantyre, Malawi: a protocol for a randomised controlled trial
    Msosa, Takondwa Charles
    Swai, Iraseni
    Sumari-de Boer, Marion
    Ngowi, Kennedy
    F. Rinke de Wit, Tobias
    Aarnoutse, Rob
    Nliwasa, Marriott
    TRIALS, 2023, 24 (01)